Treatment-Refractory Sternocostoclavicular Hyperostosis
Ralph Yachoui1, Mazen Kreidy2, Brian J Parker3
1Department of Rheumatology, Marshfield Clinic, Marshfield, Wisconsin, USA; Current affiliation: Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA. ryachoui@mednet.ucla.edu.
Insights
Sternocostoclavicular hyperostosis (SCCH) is a rare axial skeleton disorder. Pamidronate treatment failed to alleviate symptoms or improve imaging in a long-term SCCH patient.
Area of Science:
- Rheumatology
- Skeletal Disorders
- Inflammatory Conditions
Background:
- Sternocostoclavicular hyperostosis (SCCH) is an uncommon chronic inflammatory axial skeleton disorder.
- SCCH often goes unrecognized due to low awareness, presenting with shoulder, neck, and chest pain.
- Radiological findings include sternoclavicular joint sclerosis and hyperostosis.
Abstract:
Sternocostoclavicular hyperostosis (SCCH) is an infrequent chronic inflammatory disorder of the axial skeleton of unknown origin. SCCH goes often unrecognized due to a low level of awareness for the disorder. It typically presents with relapsing and remitting pain in the shoulder, neck, and anterior chest wall area with occasional swelling and tenderness of the sternoclavicular area. The diagnosis is confirmed radiologically by sclerosis and hyperostosis of the sternoclavicular joints. There have been several reports in which intravenous bisphosphonates and tumor necrosis factor-inhibitors have shown reasonable efficacy in the treatment of this disorder. We report a patient with a long history of SCCH in whom pamidronate 60 mg intravenously every 3 months for 3 years failed to reduce symptom severity and improve radiologic findings.
Related Concept Videos
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Pericarditis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Regurgitation III: Medical Management
Rheumatic Heart Disease IV: Nursing Management


